Evelyn Wang, PhD has joined Circle Pharma as its Vice President of Translational Medicine and will lead Circle’s translational team in its development of macrocycle therapeutics against intractable cancer targets.[...]
Circle Pharma raises $66 Million in Series C Financing[...]
Circle Pharma appoints Constantine Kreatsoulas, PhD as its Vice President, Research Informatics and Computational Chemistry.[...]
Circle adds experienced drug hunter Dr. James Aggen to its growing team as Vice President of Medicinal Chemistry.[...]
Renowned scientists Dr. Bruce Stillman and Dr. Alan Ashworth join Nobel laureate Dr. William Kaelin on Circle Pharma's Scientific Advisory Board.[...]
Circle Pharma Appoints Rajinder Singh, PhD as its Chief Science Officer[...]
Circle Pharma has appointed 2019 Nobel Laureate William G. Kaelin Jr., MD as its lead science advisor and chair of its SAB.[...]
Circle Pharma closes $45M series B financing led by The Column Group to support its macrocycle drug development work. [...]
Circle Pharma congratulates 2019 Nobel laureate Dr. Bill Kaelin. Dr. Kaelin advises Circle on its work to develop cyclin inhibitors for cancer., [...]
Peptide therapeutics would seem to occupy a sweet spot between small molecules and biologics. Small molecules, which represent the majority of clinical drugs, preferentially bind hydrophobic pockets or cavities, [...]